UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000009079 |
|---|---|
| Receipt number | R000010645 |
| Scientific Title | The effect of luteinizing hormone-releasing hormone antagonist in the progression prostate cancer with initial luteinizing hormone-releasing hormone agonist |
| Date of disclosure of the study information | 2012/11/01 |
| Last modified on | 2014/05/28 13:55:04 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The effect of luteinizing hormone-releasing hormone antagonist in the progression prostate cancer with initial luteinizing hormone-releasing hormone agonist
Acronym
PC-antagonist
Scientific Title
The effect of luteinizing hormone-releasing hormone antagonist in the progression prostate cancer with initial luteinizing hormone-releasing hormone agonist
Scientific Title:Acronym
PC-antagonist
Region
| Japan |
Condition
Condition
prostate cancer
Classification by specialty
| Urology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the effect of luteinizing hormone-releasing hormone antagonist, in the prostate cancer with prostate specific antigen biochemical treated with initial luteinizing hormone-releasing hormone agonist, especially associated with testosterone level 20ng/dl.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
PSA response after three months with luteinizing hormone-releasing hormone agonist
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
luteinizing hormone-releasing hormone agonist
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| 85 | years-old | >= |
Gender
Male
Key inclusion criteria
25% elevation from PSA nadir and 2.0ng/ml
Serum testosterone >20ng/dl
WHO performance status 0 or 1
WBC over 3000/mm3
Pl t over 100,000/mm3
Hgb over 8.0g/mm3
Ccr over 50ml/m
Bil less than 2.0mg/dl
GOT(AST) less than 2.5xnormal range
GPT(ALT) less than 2.5x normal range
Key exclusion criteria
Active infection
Fever elevation >38 celsius
Exclusion decided by physician
Target sample size
32
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Norihito Soga |
Organization
Aichi cancer center hospital
Division name
urology
Zip code
Address
1-1Kanokodenn, Chikusa, Nagoya
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
M-CURE
Division name
urology
Zip code
Address
TEL
Homepage URL
n-soga@aichi-cc.jp
Sponsor or person
Institute
M-CURE
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 11 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2012 | Year | 10 | Month | 09 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 11 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2012 | Year | 10 | Month | 10 | Day |
Last modified on
| 2014 | Year | 05 | Month | 28 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010645
